Proactive Investors UK - William Ransom divests Manuka Gold brand for £560,000

1 year chart

1 day chart

Epic & Msn data
Epic	RNSM
Time:	16:29:19
Mid Price:	7.88
Change Today:	2.13
Change % Today:	36.96
Fifty Two Week High:	8.33
Fifty Two Week Low:	4.13
Market Capital:	6.65

Period & price data
Period	Price
Now:	7.88
3 Months ago:
6 Months ago:
1 Year ago:

Additional information
Additional	Information
Market:	AIM
Sector:	Pharmaceuticals & Biotechnology
Epic:	RNSM
News:	Latest news
Web Site:	Ransom & Son plc(WILLIAM)
Other Articles:	12-01-2010

Ransom & Son plc(WILLIAM)

William Ransom & Son plc is a United Kingdom-based company engaged in the supply of branded medicines, vitamins and food supplements, the manufacture of pharmaceutical products, and the extraction of plant material for the healthcare, food and beverage industries. The Company operates in three divisions: consumer healthcare, pharmaceutical and natural products. Consumer healthcare includes the sale of consumer-branded healthcare products. The pharmaceutical division includes the manufacture of its own Medicines and Healthcare Products Regulatory Agency (MHRA)-licensed products, as well as pharmaceuticals and over-the-counter products for third parties. The natural products division includes the manufacture of botanical extracts used as ingredients by the pharmaceutical division and sold to third parties. During the fiscal year ended March 31, 2008, the Company collaborated with MDY Healthcare plc to sell consumer healthcare products directly to consumers.

Friday, February 05, 2010

William Ransom divests Manuka Gold brand for £560,000

Hertfordshire headquartered natural healthcare company William Ransom (AIM: RNSM) agreed the disposal of its honey-based Manuka Gold health supplements to Honey New Zealand International for £560,000. Ransom said it intends to use the proceeds to reduce debt.

Ransom chief executive Ivor Harrison commented: “The divestment releases significant working capital and is consistent with the company's strategy of creating a focused, higher margin, differentiated natural consumer healthcare business".

The Manuka Gold brand is composed of various manuka honey based products, which are believed to be effective against a wide range of bacteria, particularly the helicobacter pylori, which is associated with stomach ulcers, the group said.

The product’s primary ingredient is imported from New Zealand. The Manuka Gold brand generated annual sales of approximately £300,000 in the year ended March 2009. However Ransom said that the brand's margins are being significantly eroded due to changing distribution channels.

Ransom expects to continue the distribution of Manuka Gold to some of its client base on behalf of New Zealand Honey International, for a fee.

Other Ransom & Son plc(WILLIAM) news

12/01/10 William Ransom & Son sells Metanium cream brand for £2.2 mln

More news ►

Investors interested in Ransom & Son plc(WILLIAM) recently viewed

No investment advice

The Company is a publisher and is not registered with or authorised by the Financial Services Authority (FSA). You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Proactive investors